S&P 500   3,830.26 (+0.02%)
DOW   31,162.44 (-0.76%)
QQQ   313.75 (+0.29%)
AAPL   122.79 (+1.49%)
MSFT   231.18 (+0.96%)
FB   259.18 (+1.76%)
GOOGL   2,020.33 (+0.22%)
AMZN   3,058.95 (+0.06%)
TSLA   675.79 (-0.94%)
NVDA   541.00 (+1.63%)
BABA   239.86 (-0.13%)
CGC   32.79 (-1.26%)
GE   12.49 (-2.12%)
MU   89.23 (+1.26%)
NIO   45.76 (-2.24%)
AMD   84.12 (+2.06%)
T   28.49 (-0.49%)
F   11.64 (-1.02%)
ACB   10.81 (-0.09%)
DIS   186.10 (-2.56%)
BA   213.71 (-1.27%)
NFLX   543.02 (-0.67%)
BAC   35.02 (-2.53%)
S&P 500   3,830.26 (+0.02%)
DOW   31,162.44 (-0.76%)
QQQ   313.75 (+0.29%)
AAPL   122.79 (+1.49%)
MSFT   231.18 (+0.96%)
FB   259.18 (+1.76%)
GOOGL   2,020.33 (+0.22%)
AMZN   3,058.95 (+0.06%)
TSLA   675.79 (-0.94%)
NVDA   541.00 (+1.63%)
BABA   239.86 (-0.13%)
CGC   32.79 (-1.26%)
GE   12.49 (-2.12%)
MU   89.23 (+1.26%)
NIO   45.76 (-2.24%)
AMD   84.12 (+2.06%)
T   28.49 (-0.49%)
F   11.64 (-1.02%)
ACB   10.81 (-0.09%)
DIS   186.10 (-2.56%)
BA   213.71 (-1.27%)
NFLX   543.02 (-0.67%)
BAC   35.02 (-2.53%)
S&P 500   3,830.26 (+0.02%)
DOW   31,162.44 (-0.76%)
QQQ   313.75 (+0.29%)
AAPL   122.79 (+1.49%)
MSFT   231.18 (+0.96%)
FB   259.18 (+1.76%)
GOOGL   2,020.33 (+0.22%)
AMZN   3,058.95 (+0.06%)
TSLA   675.79 (-0.94%)
NVDA   541.00 (+1.63%)
BABA   239.86 (-0.13%)
CGC   32.79 (-1.26%)
GE   12.49 (-2.12%)
MU   89.23 (+1.26%)
NIO   45.76 (-2.24%)
AMD   84.12 (+2.06%)
T   28.49 (-0.49%)
F   11.64 (-1.02%)
ACB   10.81 (-0.09%)
DIS   186.10 (-2.56%)
BA   213.71 (-1.27%)
NFLX   543.02 (-0.67%)
BAC   35.02 (-2.53%)
S&P 500   3,830.26 (+0.02%)
DOW   31,162.44 (-0.76%)
QQQ   313.75 (+0.29%)
AAPL   122.79 (+1.49%)
MSFT   231.18 (+0.96%)
FB   259.18 (+1.76%)
GOOGL   2,020.33 (+0.22%)
AMZN   3,058.95 (+0.06%)
TSLA   675.79 (-0.94%)
NVDA   541.00 (+1.63%)
BABA   239.86 (-0.13%)
CGC   32.79 (-1.26%)
GE   12.49 (-2.12%)
MU   89.23 (+1.26%)
NIO   45.76 (-2.24%)
AMD   84.12 (+2.06%)
T   28.49 (-0.49%)
F   11.64 (-1.02%)
ACB   10.81 (-0.09%)
DIS   186.10 (-2.56%)
BA   213.71 (-1.27%)
NFLX   543.02 (-0.67%)
BAC   35.02 (-2.53%)
Log in
LON:GLB

Glanbia Share Forecast, Price & News

GBX 10.77
+0.17 (+1.60 %)
(As of 02/26/2021 03:18 PM ET)
Add
Compare
Today's Range
10.70
Now: GBX 10.77
11
50-Day Range
9.84
MA: GBX 10.20
10.50
52-Week Range
7.45
Now: GBX 10.77
11.59
Volume9,559 shs
Average Volume29,613 shs
Market Capitalization£31.58 million
P/E Ratio22.16
Dividend Yield2.51%
BetaN/A
Glanbia plc operates as a nutrition company. It operates through three segments: Glanbia Performance Nutrition, Glanbia Nutritionals, and Glanbia Ireland. The Glanbia Performance Nutrition segment manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, e-Commerce, and gyms, as well the food, drug, mass, and club channels. The Glanbia Nutritionals segment engages in the manufacture and sale of cheese, dairy and non-dairy nutritional and functional ingredients, and vitamin and mineral premixes. The Glanbia Ireland segment produces and sells a range of value added dairy ingredients and consumer products. This segment also sells animal nutrition and fertilizer products; and operates a chain of agricultural retail outlets in Ireland. The company also engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It provides its products under the Optimum Nutrition, SlimFast, BSN, Isopure, Nutramino, ABB, think!, Amazing Grass, and Body & Fit brands. The company has operations in North America, Europe, and internationally. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry Food - Major Diversified
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+353-56-7772200
Employees7,385
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£3.82 billion
Cash FlowGBX 55.17 per share
Book ValueGBX 546.30 per share

Profitability

Miscellaneous

Market Cap£31.58 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

1.06 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
GBX 10.77
+0.17 (+1.60 %)
(As of 02/26/2021 03:18 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GLB News and Ratings via Email

Sign-up to receive the latest news and ratings for GLB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Glanbia (LON:GLB) Frequently Asked Questions

What stocks does MarketBeat like better than Glanbia?

Wall Street analysts have given Glanbia a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Glanbia wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Glanbia's stock price been impacted by Coronavirus?

Glanbia's stock was trading at GBX 10 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, GLB shares have increased by 7.7% and is now trading at GBX 10.77.
View which stocks have been most impacted by COVID-19
.

How often does Glanbia pay dividends? What is the dividend yield for Glanbia?

Glanbia announced a dividend on Wednesday, February 24th. Stockholders of record on Thursday, March 25th will be given a dividend of GBX 0.16 per share on Friday, May 7th. This represents a dividend yield of 1.54%. The ex-dividend date is Thursday, March 25th. This is a boost from Glanbia's previous dividend of GBX 0.11. The official announcement can be seen at this link.
View Glanbia's dividend history
.

Is Glanbia a good dividend stock?

Glanbia pays an annual dividend of GBX 0.27 per share and currently has a dividend yield of 2.51%. The dividend payout ratio of Glanbia is 54.77%. This payout ratio is at a healthy, sustainable level, below 75%.
View Glanbia's dividend history.

Who are Glanbia's key executives?

Glanbia's management team includes the following people:
  • Ms. Siobhán Talbot, Group MD & Exec. Director (Age 57, Pay $1.39M)
  • Mr. Mark A. Garvey, Group Fin. Director & Exec. Director (Age 57, Pay $1.02M)
  • Mr. Brian Phelan, Chief Exec. Officer of Glanbia Nutritionals (Age 54, Pay $289k)
  • Mr. Hugh McGuire, Chief Exec. Officer of Glanbia Performance Nutrition (Age 50, Pay $222k)
  • Mr. Liam Hennigan, Group Director of Strategic Planning & Investor Relations
  • Ms. Martha Kavanagh, Head of Corp. Communications
  • Mr. Tom Tench, Group Corp. Devel. Director (Age 50)
  • Mr. Michael Patten, Director of Group HR & Corp. Affairs (Age 59)
  • Mr. Michael Horan, Company Sec. (Age 56)
  • Mr. Jim Bergin, Chief Exec. of Glanbia Ingredients Ireland Limited (Age 58)

Who are some of Glanbia's key competitors?

What other stocks do shareholders of Glanbia own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Glanbia investors own include Reckitt Benckiser Group (RB), Kerry Group (KRYAY), Kimberly-Clark (KMB), Glanbia (GLAPY), Glanbia (GLAPF), Diageo (DEO), Dalata Hotel Group (DAL), Bank of Ireland Group (BIRG), Atalaya Mining (ATYM) and Amryt Pharma (AMYT).

What is Glanbia's stock symbol?

Glanbia trades on the London Stock Exchange (LON) under the ticker symbol "GLB."

How do I buy shares of Glanbia?

Shares of GLB and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Glanbia's stock price today?

One share of GLB stock can currently be purchased for approximately GBX 10.77.

How much money does Glanbia make?

Glanbia has a market capitalization of £31.58 million and generates £3.82 billion in revenue each year.

How many employees does Glanbia have?

Glanbia employs 7,385 workers across the globe.

What is Glanbia's official website?

The official website for Glanbia is www.glanbia.com.

Where are Glanbia's headquarters?

Glanbia is headquartered at Glanbia House, KILKENNY,, Ireland.

How can I contact Glanbia?

Glanbia's mailing address is Glanbia House, KILKENNY,, Ireland. The company can be reached via phone at +353-56-7772200.


This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.